Drug Database
Back to search

Netherlands· NL-56fcb246a884

Waylivra 285 mg oplossing voor injectie in voorgevulde spuit

A volanesorsen product containing volanesorsen natrium, registered in Netherlands by Akcea Therapeutics Ireland Ltd. The same ATC class is registered in 11 of our 19 countries.

ATC C10AX18

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedWaylivra 285 mg oplossing voor inject…ATCC10AX18REGISTER NO.NL-56fcb246a884PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about volanesorsen natriumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Volanesorsen is registered in 11 of 19 countries.

Countries holding a registration under ATC C10AX18 (volanesorsen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search volanesorsen products by name

Volanesorsen · ATC C10AX18

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
VOLANESORSEN NATRIUM
Manufacturer
Akcea Therapeutics Ireland Ltd
Country
Netherlands (NL)
ATC code
C10AX18
ATC class
Volanesorsen
Defined daily dose
20 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/19/1360

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Volanesorsen in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All volanesorsen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a2a95f04-4739-4b36-9ae3-d32b37e7afe6
GET /v1/drugs/a2a95f04-4739-4b36-9ae3-d32b37e7afe6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": null,
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/waylivra-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Volanesorsen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp121713",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "VOLANESORSEN NATRIUM"
  ],
  "leaflet_url": null,
  "authorised_at": "2019/05/03",
  "procedure_number": "EMEA/H/C/004538",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/19/1360",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about volanesorsen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console